The LeVair Skin Booster Line is a premium collection of next-generation skin boosters engineered to deliver all-in-one skin rejuvenation with medical-grade precision. Designed for aesthetic professionals who demand the very best in skin science, LeVair combines innovation, performance, and versatility across a comprehensive range of advanced formulations.

Powered by hybrid technology, each LeVair booster blends multiple high-performance active ingredients - including multi-weight hyaluronic acid, peptides, PDRN, succinic acid, PLLA, and other regenerative compounds - to target hydration, brightening, collagen stimulation, skin repair, and volume restoration in a single treatment.

With 16 specialised booster types across the line, LeVair allows practitioners to tailor treatments precisely to individual skin concerns, from deep hydration and glow enhancement to structural rejuvenation and anti-aging correction.

• LeVair 135 The Ultimate Hydration Skin Booster is for intense hydration, skin plumping, and collagen stimulation.
• LeVair PLLA Liquid Skin Booster is for volume enhancement & collagen stimulation.
• LeVair The Eye Revive PN Booster gel is for dark circles, fine eye wrinkles & eye radiance 
• LeVair Even Better Radical Brightening Triple Booster is for skin brightening, dullness, pigmentation  & tone correction 
• LeVair PDRN True Repair with PN is for skin repair & regeneration 
• LeVair Super NMN is for anti-aging & wrinkle reduction 
• LeVair PLLA Rich is for a long-term volume & structural support 
• LeVair CaHA Radiance Plus is for firming, volumizing & collagen stimulation 
• LeVair Rich Ultimate is for advanced skin regeneration, firming, and long-term volume restoration. 

These products are not recommended for individuals with severe allergies, particularly those with a history of anaphylaxis or multiple severe allergies. Additionally, they should not be used by patients who have a known allergy to Gram-positive bacterial proteins or lidocaine present in these formulations.

IMPORTANT SAFETY INFORMATION

Do not use any product form the LeVair Skin Booster Line if you have a history of multiple severe alergies/severe alergic reactions (anaphylaxis). Additionaly, avoid it if you are alergic to lidocaine or the Gram-positive bacterial proteins used in this product, or if you have previously experienced alergic reactions to hyaluronic acid-based skin boosters.

POST-TREATMENT PRECAUTIONS AND SAFETY CONSIDERATIONS

Post-Treatment Care Instructions: Limit strenuous exercise, sun exposure, heat, and alcohol consumption for the first 24 hours following treatment, as these factors may contribute to temporary redness, swelling, or itching at the application site. 

Important Safety Warnings and Contraindications:

• Inform your specialist if you are currently taking medications that may prolong bleeding time, such as aspirin, ibuprofen, or other blood-thinning agents, as these can increase the risk of bruising or bleeding at the application site.

• Notify your specialist in advance if you plan to undergo laser therapy, chemical peels, or any other cosmetic procedures after this treatment, as these may increase the risk of inflammatory reactions at the treatment site.

• Advise your specialist if you are receiving immunosuppressive therapy, as this may elevate the risk of infection.

• Inform your specialist if you are pregnant or breastfeeding, as the safety of this product has not been established during pregnancy or lactation.

• Discuss with your specialist if you have a history of excessive scarring (thick or hard scars), as the safety of this product in such cases has not been determined.

POSSIBLE SIDE EFFECTS

Commonly reported side effects include redness, lumps or bumps, swelling, bruising, pain, tenderness, firmness, discoloration, and itching. 

Most of these side effects typically resolve within seven days. 

There also might be inflammation, nodules, unsatisfactory results, lack of improvement, allergic reactions, anxiety, blood vessel blockage, infection, dry skin, changes in sensation, and abscesses.